UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Features, Treatment, and Outcome in 102 Adult and Pediatric Patients with Localized High-Grade Synovial Sarcoma

Sarcoma, 2011, Vol.2011 (2011), p.53-59

2011

Volltextzugriff (PDF)

Clinical features and outcomes of 20 patients with abdominopelvic desmoplastic small round cell tumor

European journal of surgical oncology, 2017-02, Vol.43 (2), p.423-431

2017

Volltextzugriff (PDF)

Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma

Complexity (New York, N.Y.), 2012, Vol.2012 (2012), p.550-553

2012

Volltextzugriff (PDF)

Primary non‐Hodgkin's lymphoma of bone. A clinicopathologic study

Cancer, 1994-02, Vol.73 (4), p.1194-1199

1994

Volltextzugriff (PDF)

Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia

Journal of endocrinological investigation, 2000-04, Vol.23 (4), p.263-267

2000

Volltextzugriff (PDF)

Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial

Journal of clinical oncology, 1992-04, Vol.10 (4), p.580-586

1992

Volltextzugriff (PDF)

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer

Journal of clinical oncology, 1998-04, Vol.16 (4), p.1340-1349

1998

Volltextzugriff (PDF)

Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10006-10006

2010

Volltextzugriff (PDF)

Extragonadal germ cell tumors. A 14‐year Toronto experience

Cancer, 1994-04, Vol.73 (7), p.1971-1979

1994

Volltextzugriff (PDF)

Advances in chemotherapy for small cell lung cancer

Seminars in oncology, 1994-02, Vol.21 (1 Suppl 1), p.38-42

Blackstein, M E

1994

Volltextzugriff (PDF)

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2009-03, Vol.373 (9669), p.1097-1104

2009

Volltextzugriff (PDF)

Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma

Journal of clinical oncology, 1987-04, Vol.5 (4), p.635-640

1987

Volltextzugriff (PDF)

Lymph node metastasis in soft tissue sarcoma in an extremity

Clinical orthopaedics and related research, 2004-09 (426), p.129-134

2004

Volltextzugriff (PDF)

Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment

Canadian journal of gastroenterology, 2006-03, Vol.20 (3), p.157-163

2006

Volltextzugriff (PDF)

The relationship between growth and androstenedione metabolism in four cell lines of human breast carcinoma cells in culture

Molecular and cellular endocrinology, 1985-07, Vol.41 (2), p.197-203

1985

Volltextzugriff (PDF)

The challenge of conducting pharmacoeconomic evaluations in oncology using crossover trials: The example of sunitinib for gastrointestinal stromal tumour

European journal of cancer (1990), 2008-05, Vol.44 (7), p.972-977

2008

Volltextzugriff (PDF)

Intraocular lymphoma: report of three cases and review of the literature

American journal of clinical oncology, 1988-04, Vol.11 (2), p.126-130

1988

Volltextzugriff (PDF)

The Combination of p53 Mutation and neu/erbB-2 Amplification Is Associated With Poor Survival in Node-Negative Breast Cancer

Journal of clinical oncology, 2004-01, Vol.22 (1), p.86-96

2004

Volltextzugriff (PDF)

The GOLD reGISTry: A global observational registry collecting longitudinal data on patients with advanced GIST—Second annual summary

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.10092-10092

2010

Volltextzugriff (PDF)

The intracellular control of aromatase activity by 5α-reduced androgens in human breast carcinoma cells in culture

The journal of clinical endocrinology and metabolism, 1984-03, Vol.58 (3), p.467-472

1984

Volltextzugriff (PDF)

Aromatase in human breast carcinoma

Cancer research (Chicago, Ill.), 1982-08, Vol.42 (8 Suppl), p.3369s-3372s

1982

Volltextzugriff (PDF)

Novel statistical analysis of long-term survival to account for crossover in a phase III trial of sunitinib (SU) vs. placebo (PL) in advanced GIST after imatinib (IM) failure

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.10524-10524

2008

Volltextzugriff (PDF)

Doxorubicin-cisplatin chemotherapy for high-grade nonosteogenic sarcoma of bone. Comparison of treatment and control groups

Canadian Journal of Surgery, 1999-06, Vol.42 (3), p.190-199

1999

Volltextzugriff (PDF)

DNA content and estrogen receptors in primary carcinoma of the breast

Canadian journal of surgery, 1991-08, Vol.34 (4), p.349-355

1991

Volltextzugriff (PDF)

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

Journal of clinical oncology, 1998-04, Vol.16 (4), p.1340-1349

1998

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(82)
Buchkapitel
(1)

Sprache

Englisch
(83)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Clinical Features, Treatment, and Outcome in 102 Adult and Pediatric Patients with Localized High-Grade Synovial Sarcoma

Clinical features and outcomes of 20 patients with abdominopelvic desmoplastic small round cell tumor

Topotecan and Cyclophosphamide in Adults with Relapsed Sarcoma

Primary non‐Hodgkin's lymphoma of bone. A clinicopathologic study

Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia

Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer

Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001

Extragonadal germ cell tumors. A 14‐year Toronto experience

Advances in chemotherapy for small cell lung cancer

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

Hepatic arterial infusion of mitoxantrone in the treatment of primary hepatocellular carcinoma

Lymph node metastasis in soft tissue sarcoma in an extremity

Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment

The relationship between growth and androstenedione metabolism in four cell lines of human breast carcinoma cells in culture

The challenge of conducting pharmacoeconomic evaluations in oncology using crossover trials: The example of sunitinib for gastrointestinal stromal tumour

Intraocular lymphoma: report of three cases and review of the literature

The Combination of p53 Mutation and neu/erbB-2 Amplification Is Associated With Poor Survival in Node-Negative Breast Cancer

The GOLD reGISTry: A global observational registry collecting longitudinal data on patients with advanced GIST—Second annual summary

The intracellular control of aromatase activity by 5α-reduced androgens in human breast carcinoma cells in culture

Aromatase in human breast carcinoma

Novel statistical analysis of long-term survival to account for crossover in a phase III trial of sunitinib (SU) vs. placebo (PL) in advanced GIST after imatinib (IM) failure

Doxorubicin-cisplatin chemotherapy for high-grade nonosteogenic sarcoma of bone. Comparison of treatment and control groups

DNA content and estrogen receptors in primary carcinoma of the breast

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

Suchergebnisse filtern